AVE 33.3% 0.2¢ avecho biotechnology limited

success! , page-40

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735
    Evo, technically yes a phase I, but not like the average untested drug.
    The beauty of of delivery platform is delivering drugs we know already work, but just haven't been delivered transdermally before.
    We know the efficacy of the drug. As I have said the therapeutic plasma levels have been achieved for multiple dose, safely. The patch doesn't know if the body is in pain, it just delivers it. Similarly the body doesn't care how the blood plasma level is achieved, as long as it's too a sustained therapeutic level.
    So yes it is a phase I, but in reality it's a whole lot more.
    Neura will jump on this data.
    I'd expect plenty of media and just to appease playez, a ground breaking publication.

    By the way does anyone want to chat about anti-mastitis, anti-acne, maybe our product going into world leading Novartis voltaren in India.

    For the newies here, please feel free to see our extensive pipeline.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.